Braeburn, a subsidiary of Apple Tree Partners, has gained commercialization rights to Titan Pharmaceuticals' long-acting subdermal implant in the US and Canada, under the signed license agreement. The investigational subcutaneous implant, ...
Tags: Braeburn, Marketing Rights, subsidiary of Apple Tree Partners, Medicine
Titan Pharmaceuticals has completed preclinical study of its long-term,non-fluctuating dopamine agonist,as a treatment for Parkinson's disease. The preclinical study included in-vitro characterization of implant formulations of two ...
Tags: Titan Pharmaceuticals, Parkinson's disease, ProNeura drug